Back to SYRE
EMERALD MUTUAL FUND ADVISERS TRUST → SYRE
EMERALD MUTUAL FUND ADVISERS TRUST SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$32.6M
Q3 2026
Peak value
$35.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $13.5M |
| Q1 2026 | $20.6M |
| Q2 2026 | $35.6M |
| Q3 2026 | $32.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $32.6M | 366.1K | — | — |
| Q2 2026 | $35.6M | 401.3K | — | — |
| Q1 2026 | $20.6M | 408.1K | — | — |
| Q4 2025 | $13.5M | 412.4K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M